2-26310718-T-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001321971.2(ADGRF3):​c.2806A>C​(p.Ile936Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000959 in 1,460,256 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I936V) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000096 ( 0 hom. )

Consequence

ADGRF3
NM_001321971.2 missense

Scores

17

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.456

Publications

1 publications found
Variant links:
Genes affected
ADGRF3 (HGNC:18989): (adhesion G protein-coupled receptor F3) Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway and cell surface receptor signaling pathway. Predicted to be located in plasma membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
SELENOI (HGNC:29361): (selenoprotein I) The multi-pass transmembrane protein encoded by this gene belongs to the CDP-alcohol phosphatidyltransferase class-I family. It catalyzes the transfer of phosphoethanolamine from CDP-ethanolamine to diacylglycerol to produce phosphatidylethanolamine, which is involved in the formation and maintenance of vesicular membranes, regulation of lipid metabolism, and protein folding. This protein is a selenoprotein, containing the rare selenocysteine (Sec) amino acid at its active site. Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2016]
SELENOI Gene-Disease associations (from GenCC):
  • spastic paraplegia 81, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • neurodevelopmental disorder
    Inheritance: AR Classification: MODERATE Submitted by: PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10737622).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001321971.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADGRF3
NM_001321971.2
MANE Select
c.2806A>Cp.Ile936Leu
missense
Exon 10 of 14NP_001308900.1A0A494C083
ADGRF3
NM_001145168.1
c.3010A>Cp.Ile1004Leu
missense
Exon 11 of 13NP_001138640.1Q8IZF5-1
ADGRF3
NM_001145169.1
c.2803A>Cp.Ile935Leu
missense
Exon 10 of 13NP_001138641.1Q8IZF5-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADGRF3
ENST00000651242.2
MANE Select
c.2806A>Cp.Ile936Leu
missense
Exon 10 of 14ENSP00000498434.1A0A494C083
ADGRF3
ENST00000311519.5
TSL:1
c.3010A>Cp.Ile1004Leu
missense
Exon 11 of 13ENSP00000307831.1Q8IZF5-1
ADGRF3
ENST00000447444.5
TSL:1
n.2413A>C
non_coding_transcript_exon
Exon 8 of 13ENSP00000404775.1Q8IZF5-2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000813
AC:
2
AN:
245960
AF XY:
0.0000150
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000182
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000959
AC:
14
AN:
1460256
Hom.:
0
Cov.:
32
AF XY:
0.0000110
AC XY:
8
AN XY:
726278
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33446
American (AMR)
AF:
0.00
AC:
0
AN:
44448
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26078
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39678
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85904
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53326
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000126
AC:
14
AN:
1111284
Other (OTH)
AF:
0.00
AC:
0
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
0.26
DANN
Benign
0.90
DEOGEN2
Benign
0.017
T
Eigen
Benign
-0.98
Eigen_PC
Benign
-0.88
FATHMM_MKL
Benign
0.068
N
LIST_S2
Benign
0.69
T
M_CAP
Benign
0.0057
T
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.46
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.038
Sift
Benign
0.33
T
Sift4G
Benign
0.80
T
Polyphen
0.0010
B
Vest4
0.18
MutPred
0.34
Gain of catalytic residue at I1004 (P = 0.2026)
MVP
0.11
MPC
0.084
ClinPred
0.027
T
GERP RS
-3.5
Varity_R
0.10
gMVP
0.077
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781185576; hg19: chr2-26533586; API